Updated: January 4, 2026
Adenocard Shortage Update: What Patients Need to Know in 2026
Author
Peter Daggett

Summarize with AI
- Is Adenocard in a Shortage in 2026?
- Why Is This Drug Important for Patients?
- If My Procedure Was Delayed Because of Adenosine Availability, What Should I Do?
- What About Emergency Use? Can the ER Run Out of Adenosine?
- What Are the Most Common Side Effects Patients Experience?
- How Can I Find Out If My Hospital Has Adenosine in Stock?
- Key Takeaways for Patients and Caregivers
Wondering about the Adenocard (adenosine) shortage status in 2026? Here is an up-to-date breakdown of supply, what patients should know, and what to do.
If you or a loved one has been told that Adenocard (adenosine) may not be available for an upcoming procedure or emergency treatment, it is natural to have questions. This post provides a straightforward update on Adenocard's availability in 2026 and explains what patients and caregivers need to know — including what your care team should be doing to ensure you get the right treatment.
Is Adenocard in a Shortage in 2026?
As of 2026, Adenocard (adenosine injection) is not on the FDA's current drug shortage list. This means there is no declared national shortage at this time. However, it is important to understand what that means in practice: the absence of a national shortage does not guarantee that every hospital, clinic, or medical distributor has adequate stock. Localized supply disruptions, distributor allocation issues, and temporary back-orders happen regularly with injectable medications — even when the FDA has not made an official shortage declaration.
Adenosine has experienced significant supply disruptions in the past. The most notable period was during the 2011–2012 injectable drug shortage crisis in the United States, when dozens of sterile injectables — including adenosine — faced widespread availability problems. That shortage has since resolved, and generic adenosine is now widely produced.
Why Is This Drug Important for Patients?
Adenocard is not a drug you take at home. It is given intravenously in a hospital or clinical setting by a trained healthcare provider. It is used for two main purposes:
- Stopping a rapid heart rate (PSVT): If you experience a sudden racing heartbeat — heart rates of 150–250 beats per minute — caused by paroxysmal supraventricular tachycardia, adenosine is the first drug emergency teams reach for. It briefly pauses the abnormal electrical circuit causing the rapid rhythm and restores your heart to its normal rate.
- Heart stress testing: For patients who cannot walk on a treadmill due to arthritis, peripheral artery disease, or other limitations, adenosine is given as an IV drip during a nuclear heart scan to mimic the effect of exercise on the heart. This helps doctors check for blocked arteries or heart disease.
If My Procedure Was Delayed Because of Adenosine Availability, What Should I Do?
First, talk to your doctor or the facility where your procedure is scheduled. Ask them specifically:
- Is this facility able to obtain adenosine through an alternate distributor or manufacturer?
- Can the procedure be done using regadenoson (Lexiscan) instead of adenosine for stress testing?
- Is the procedure truly urgent, or can it safely be rescheduled for when supply is restored?
If your procedure is a scheduled stress test that is being delayed due to adenosine availability, ask whether regadenoson (Lexiscan) can be used as a substitute. Many cardiology programs have already transitioned to regadenoson as their primary pharmacologic stress agent, and it is equally effective for diagnosing coronary artery disease through nuclear imaging.
What About Emergency Use? Can the ER Run Out of Adenosine?
Emergency departments and hospitals are required to maintain formulary drugs and have backup protocols for drug shortages. If a hospital is running low on adenosine, pharmacy teams should already be sourcing alternate NDC numbers, contacting secondary distributors, and preparing backup protocols using IV verapamil or IV diltiazem — both of which are effective alternatives for PSVT.
If you are in an emergency with a dangerous heart rate, rest assured that trained emergency teams have established backup protocols. Your care will not be compromised by a supply issue that a well-run hospital pharmacy has anticipated and planned for.
What Are the Most Common Side Effects Patients Experience?
Patients who have received adenosine in the ER often describe a brief but startling experience. Because the drug works so fast, it temporarily stops the heart's electrical signal at the AV node — and many people feel a sudden flush of warmth, chest tightness, shortness of breath, or even a terrifying sense of impending doom. These feelings last only 5–20 seconds because adenosine is cleared from the body in under 10 seconds. While alarming in the moment, these sensations are a normal part of the drug's action and resolve almost immediately.
How Can I Find Out If My Hospital Has Adenosine in Stock?
If you are scheduled for a procedure that uses adenosine, your care team should be handling the sourcing. But if you want peace of mind or are helping coordinate care, medfinder can help you find which providers and pharmacies near you have adenosine available. For more tools, see our guide on how to find Adenocard in stock near you.
Key Takeaways for Patients and Caregivers
- Adenocard is not on the FDA shortage list in 2026, but localized supply issues can still occur
- For stress testing, ask your provider if regadenoson (Lexiscan) can be used as a substitute
- For emergency PSVT, hospitals have backup protocols — your care will be managed appropriately
- Always communicate openly with your healthcare team about any concerns regarding your procedure or medication availability
Frequently Asked Questions
As of 2026, adenosine injection is not listed on the FDA's active drug shortage list. However, localized supply disruptions and distributor back-orders can still affect individual facilities. The absence of a national shortage does not guarantee supply at every location.
Ask your provider whether regadenoson (Lexiscan) can be used as an alternative pharmacologic stress agent. Many facilities have already transitioned to regadenoson, which is equally effective for nuclear myocardial perfusion imaging.
Yes. Adenosine experienced supply disruptions during the 2011–2012 U.S. injectable drug shortage crisis. That shortage has since resolved, and generic adenosine is now produced by multiple manufacturers. However, supply challenges can recur.
Hospitals with shortage management protocols will substitute IV verapamil or IV diltiazem for PSVT treatment. Both are non-dihydropyridine calcium channel blockers with similar conversion rates. For stress testing, regadenoson (Lexiscan) is the standard alternative.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Adenocard also looked for:
More about Adenocard
36,837 have already found their meds with Medfinder.
Start your search today.





